BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3701)

  • 21. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE; Eff J; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z; Hollósi Z; Iskum M
    Ther Hung; 1984; 32(2):74-8. PubMed ID: 6152819
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Rydén L
    Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy and differential therapy with beta sympathicolytic drugs].
    Frisch P
    Med Klin; 1975 Oct; 70(42):1682-7. PubMed ID: 241898
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trimepranol and propranolol (author's transl)].
    Kuchar L; Jedlicka K
    Cas Lek Cesk; 1973 Sep; 112(38):1181-2. PubMed ID: 4148031
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 30. Patient preference in antianginal therapy. Proceedings of a symposium. Madeira, 21-22 October, 1988.
    Drugs; 1989; 38 Suppl 2():1-91. PubMed ID: 2575974
    [No Abstract]   [Full Text] [Related]  

  • 31. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 34. Nadolol: a new beta-blocker that may increase patient compliance.
    Gever LN
    Nursing; 1980 Oct; 10(10):57. PubMed ID: 6106172
    [No Abstract]   [Full Text] [Related]  

  • 35. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
    Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 40. [What is assured in the therapy of angina pectoris and hypertension with beta receptor blockers?].
    Rettig G
    Internist (Berl); 1980 Dec; 21(12):711-7. PubMed ID: 6110642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.